The Safety and Immunogenicity Study of the Recombinant Zoster Vaccine (CHO Cell)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 9, 2023

Primary Completion Date

December 6, 2023

Study Completion Date

December 6, 2023

Conditions

Herpes Zoster

Interventions

BIOLOGICAL

REC610

administered as 2 intramuscular (IM) injections in healthy adults aged 40 years and older

BIOLOGICAL

Shingrix

Trial Locations (1)

Pharma Peak Research Philippines,Inc., Makati City

All Listed Sponsors

lead

Jiangsu Rec-Biotechnology Co., Ltd.

INDUSTRY